期刊文献+

氢溴酸达非那新的合成研究 被引量:6

Study on the Synthesis of Darifenacin Hydrobromide
下载PDF
导出
摘要 以(S)-(-)-3-羟基吡咯烷盐酸盐为原料,经氨基和羟基同时保护、取代、脱N-保护基、氰基水解,与L-(+)-酒石酸成盐等4步反应,制得3-(S)-(-)-(1-氨甲酰基-1,1-二苯基甲基)四氢吡咯酒石酸盐,经皂化后与5-(2-溴乙基)-2,3-二氢苯并呋喃缩合、成盐制得氢溴酸达非那新,总收率为23.4%。产物经1H NMR和质谱进行了确认。对文献工艺条件进行了优化,适合于工业化生产,同时对文献报道目标化合物的旋光度数据进行了修正。 Darifenacin hydrobromide was prepared from (S)-(-)-3-hydroxylpyrrolidine hydroehloride as raw material by NH and OH protection, replacement with 1,1-diphenylacetonitrile, deproteetion, hydrolysis and salt formation to give the key intermediate 3-(S)-(-)-(1-carbomoyl-1,1-diphenylmethyl)pyrrolidine L- (+)-tartrate. followed by saponification and condensation with 5-(2-bromoethyl)-2,3-dihydrobenzofuran. Then darifenacin hydrobromide was obtained by salt formation with 40 % HBr with an overall yield of about 23.4%. The product was confirmed by ~H NMR and MS. Technical parameters were optimized, So that the process was more suitable for industrialization. The optical rotatory degree of darifenacin hydrobromide was tested, which was [a]D^20= + 49.4° (c = 1, CH2Cl2).
出处 《化学世界》 CAS CSCD 北大核心 2009年第2期100-103,共4页 Chemical World
关键词 氢溴酸达非那新 尿失禁 合成 darifenacin hydrobromide incontinence synthesis
  • 相关文献

参考文献5

  • 1Machenzie A R, Cross P E. Pyrrolidine derivatives [P]. EP:0 388 054, 1990-02-03.
  • 2Machenzie A R, Cross P E. Pyrrolidine dcrivatives [P].US:5 096 890, 1992-08-17.
  • 3刘长欢,俞雄,袁哲东.氢溴酸达非那新的合成[J].中国医药工业杂志,2007,38(12):825-827. 被引量:10
  • 4Merli V, Canavesi A, Daverio P. processes for preparing darifenacin hydrobromide [ P ]. US: 197 631, 2007-08-23.
  • 5Merli V, Canavesi A, Daverio P, et al. Pure darifenacin hydrobromidc substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof[P]. WO:076 159, 2007-07-07.

二级参考文献4

  • 1Nunn PA, Greengrass PM, Newgreen DT, et al. The binding profile of the novel muscarinic receptor antagonist the five cloned human muscarinic receptors expressed in CHO cells [J]. Br JPharmacol, 1996, 117 (suppl) : 130P.
  • 2Newgreen DT, Anderson DW, Carter AJ. Darifenacin: a novel bladder-selective muscarinic antagonist for the treatment of urge incontinence [J]. J Urol, 1996, 155 (suppl. 5) : 156.
  • 3Cross PE, Mackeazie AR. Preparation of pyrrolidine derivatives as muscarinic receptor antagonists: EP, 0338054[P]. 1990-11-19. (CA 1991, 114: 247125)
  • 4Dunn JP, Ackerman NA, Tomolonis A J, et al. Analgetic and antiinflammatory 7-aroylbenzofuran-5-ylacetic acids and 7-aroylbenzothiophene-5-ylacetic acids [J]. J Med Chem, 1986, 29 (11) : 2326-2329.

共引文献9

同被引文献30

  • 1梁晓丽,胡咏川,张玉风,吴娜,左明新.达非那新[J].中国新药杂志,2006,15(20):1790-1791. 被引量:2
  • 2谢单丹.膀胱过动症治疗药 达非那新(darifenacin)[J].世界临床药物,2007,28(5):317-317. 被引量:3
  • 3姚韧辉,王德才,江建.3-(S)-(-)-(1-氨甲酰基-1,1-二苯基甲基)吡咯烷的制备[J].化工时刊,2007,21(6):34-35. 被引量:1
  • 4Nunn PA, Greengrass PM, Newgreen DT, et al. The binding profile of the novel muscarinic receptor antagonist the five cloned human muscarinic receptors expressed in CHO cells [J]. Br J Pharmacol, 1996, 117: 130.
  • 5Newgreen DT, Anderson DW, Carter AJ. Darifenacin: a novel bladder-selective muscarinic antagonist for the treatment of urge incontinence [J]. J Urol, 1996, 155: 156.
  • 6Alabaster RJ, Cottrell IF. The synthesis of 5-substituted 2,3-dihydrobenzofunars [J]. Synthesis, 1988, 27: 950-952.
  • 7Dunn JP, Ackerman NA, Tomolonis AJ. Analgetic and antiinflammatory 7-aroylbenzofuran-5-ylacetic acids and 7-aroylbenzothiophene-5-ylacetic acids[J]. J Med Chem, 1986, 29 (11) : 2326-2329.
  • 8Nystrom RF, Brown WG. Reduction organic compounds by lithium aluminum hydride.Ⅱ . Carboxylic acids [J]. J Am Chem Soc, 1947, 69 (10) : 2548-2549.
  • 9Cross PE, Mackenzie AR. Pyrrolidine derivatives: EP, 0388054 [P]. 1990-09-19. (CA 1991, 114: 247125).
  • 10Dunn P J, Matthews JG, Newbury T J, et al. Stable hydrate of a muscarinic receptor antagonist: US, 6930188 [P]. 2005-08-16. (CA 2003, 139: 292143).

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部